{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-200017","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2022-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.411419+00:00","generated_at":"2026-06-24T09:34:21.490016+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Revolution Medicines raises $248M net in public offering of 13.225M shares at $20/share","bullets":["Sold 13.225M shares (including full exercise of underwriters' option) at $20.00 per share public price.","Net proceeds of approximately $248.0M after underwriting discounts and offering expenses.","Underwriters include J.P. Morgan, Cowen, Guggenheim; lock-up period of 60 days for directors and officers.","Offering closed on July 22, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-200017","json":"https://secwatch.observer/filing/0001193125-22-200017.json","markdown":"https://secwatch.observer/filing/0001193125-22-200017.md","text":"https://secwatch.observer/filing/0001193125-22-200017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312522200017/0001193125-22-200017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312522200017/d61456d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:34:21.490016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}